The chief executive of Botanical Solution Inc. (BSI) speaks about the development of QS-21 adjuvant for vaccines from Quillaja saponaria trees grown in BSI labs
Ginkgo aims to support customers improving the performance of T-cell and NK-cell based CAR therapies to treat solid tumors, autoimmune, and other diseases.